Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$390K Sell
80,901
-24,619
-23% -$149K 0.01% 2679
2026
Q1
$650K Buy
+105,520
New +$876K 0.01% 1783
2025
Q3
Sell
-67,304
Closed -$875K 3168
2025
Q2
$875K Buy
67,304
+45,900
+214% +$690K 0.04% 746
2025
Q1
$540K Buy
+21,404
New +$636K 0.03% 974
2024
Q3
Sell
-4,726
Closed -$284K 2534
2024
Q2
$284K Sell
4,726
-1,254
-21% -$71.7K 0.02% 997
2024
Q1
$308K Sell
5,980
-3,148
-34% -$155K 0.04% 830
2023
Q4
$368K Buy
+9,128
New +$268K 0.08% 469
2023
Q2
Sell
-16,763
Closed -$280K 1778
2023
Q1
$280K Buy
+16,763
New +$237K 0.06% 707

Other funds holding RXST

XTX Topco's RXST Position: Q2 2026 in Review

XTX Topco reduced its RxSight (RXST) stake by 23% in Q2 2026, selling an estimated $149K and leaving 80,901 shares worth $390K. The position accounts for 0.01% of the portfolio, ranked #2679.

XTX Topco first reported a position in RXST in Q1 2023 and has held it in 8 quarters since. The position peaked at $875K in Q2 2025. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • XTX Topco held 80,901 shares of RxSight worth $390K as of Q2 2026.
  • XTX Topco sold 24,619 RxSight shares in Q2 2026, an estimated $149K.
  • RxSight made up 0.01% of XTX Topco's portfolio in Q2 2026, its #2679 holding.
  • XTX Topco first reported a position in RxSight in Q1 2023 and has held it in 8 quarters since.
  • XTX Topco's RxSight position peaked at $875K in Q2 2025.
  • 151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.